| A Canary's-Eye View | |
| Introduction | |
| Articles | |
| Challenges | |
| Conditions | |
| Metabolic Basis | |
| Resources | |
| Supplements | |
 |
|
| Links | |
|
|
| Other AltMed | |
| What's New | |
| Search | |
| CHC Home | |
- Detoxification Enzyme Systems, by DeAnn J. Liska, Ph.D. (Altern Med Rev 1998;3(3):187-198)
- (B1) Deficiency > deficient AK
- Amino Acids search for p5p
- Pterins from glutamate, not back from H4folate AMALGAM archives -- September 1998 (#285) (see access directions).
- ONElist : Rejuvenation (HGH) Recommended by Ray Hg S., mercure@primenet.com, on AMALGAM list
- Advanced Techniques For Overcoming CFS, FMS and GWS
- Fibromyalgics have low IGF-1 AMALGAM archives -- August 1998 (#1262)(see access directions).
- Mercury inhibits molybdopterin reduction AMALGAM archives -- August 1998 (#1317)(see access directions).
- Methionine & Homocysteine
- Introduction to Glycolysis
- Nitrogen Metabolism & Biochemical Nutrition
- Amino Acids
- Table of digestive enzymes
- Nitrogen Metabolism & Biochemical Nutrition
- The THCME Medical Biochemistry Page
- Veris Online - publications on antioxidant research
- Materials for Pharmacology 308, by Dr. Brian Creese at the University of Queensland Brisbane:
- PK308 Resources - six complete tutorials on the P450 system
- Subject Outline: PK308 - including books
- P-Glycoproteins:
- Protease inhibitors - - P-glycoproteins help to block toxins from entering the bloodstream by lining intestine cells, and they aid the liver and kidney in eliminating toxins through bile and urine.
- About Transporters - Progesterone inhibits P-glycoproteins
- P-glycoprotein and HIV - "P-gp inhibitors include the immunosuppressant cyclosporin A and its non-immunosuppressive analogue PSC833 (valspodar); the calcium channel blocker verapamil; the PIs RTV, SQV, NFV and possibly IDV; the progesterone antagonist mifepristone (RU486); the antiarrhythmic agent quinidine; the sedative midazolam; the anti-estrogen tamoxifen; the antibiotic erythromycin; the antifungal ketoconazole; the peptide chemosensitizers reversins 121 and 205; the acridonecarboxamide derivative GF120918 (or GG918); and the cyclopropyldibenzosuberane LY335979. (Drach 1996, Fardel 1996 – Anticancer Drugs, Huisman 2000 – AIDS, Mayer 1997, Sharom 1999, Twentyman 1991 and Yumoto 1999)"
- Digestive Diseases & Sciences - November 1999. "Cholestatic effect of CyA is worsened by P-gp inhibitors" ie, P-glycoprotein assists bile flow.
- Functional Medicine:
23 October 2000